Home›People›Ethan Mann
EM

Ethan Mann

Co-Founder and CEO, director at Ardego Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Ethan Mann

Ethan Mann is a co-founder and CEO, director at Ardego Therapeutics.

Experience

This experience comes from Ethan Mann's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ethan Mann in the role, so the role may have started earlier or lasted longer.

Ardego Therapeutics, Inc. Current
Co-Founder and CEO, director
2026 – Present · Gaithersburg, MD
Develops targeted therapies for people with cancer.
Ethan Mann Strategic Advisory Current
Principal
2025 – Present
LemVega Biotech Venture Fund Current
Venture Partner
2023 – Present
EnteroTrack LLC.
Fractional CFO
2025 – 2026
OrganiShield
Chief Executive Officer
2023 – 2025
Blacktip Ventures
Managing Partner
2019 – 2025
Validus Cellular Therapeutics
Chief Executive Officer
2019 – 2023
Sharklet Technologies
COO and VP
2013 – 2019
The Ohio State University Medical Center
Postdoctoral Fellow
2010 – 2013
University of Nebraska Medical Center
Graduate Fellow
2005 – 2010

Key Colleagues at Startups

The people Ethan Mann works with at each company, as listed on that company's latest Form D.

Ardego Therapeutics, Inc. · Form D, Jun 3, 2026
Beverly Packard
Beverly Packard
Co-Founder and Chief Science Officer, director

Sources

  1. SECArdego Therapeutics, Inc. Form D, filed Jun 3, 2026